BPTIX
Price
$193.12
Change
+$3.17 (+1.67%)
Updated
May 9 closing price
Net Assets
6.66B
RGAHX
Price
$71.62
Change
-$0.09 (-0.13%)
Updated
May 9 closing price
Net Assets
285.48B
Ad is loading...

BPTIX vs RGAHX

Header iconBPTIX vs RGAHX Comparison
Open Charts BPTIX vs RGAHXBanner chart's image
Baron Partners Institutional
Price$193.12
Change+$3.17 (+1.67%)
VolumeN/A
Net Assets6.66B
American Funds Growth Fund of Amer R5E
Price$71.62
Change-$0.09 (-0.13%)
VolumeN/A
Net Assets285.48B
BPTIX vs RGAHX Comparison Chart
Loading...
View a ticker or compare two or three
VS
BPTIX vs. RGAHX commentary
May 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BPTIX is a Buy and RGAHX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RGAHX has more cash in the bank: 285B vs. BPTIX (6.66B). RGAHX pays higher dividends than BPTIX: RGAHX (0.54) vs BPTIX (0.00). BPTIX was incepted earlier than RGAHX: BPTIX (16 years) vs RGAHX (9 years). BPTIX (1.99) is less costly to investors than RGAHX (0.44). RGAHX is a more actively managed with annual turnover of: 25.00 vs. BPTIX (1.00). RGAHX has a lower initial minimum investment than BPTIX: RGAHX (250) vs BPTIX (1000000). BPTIX annual gain was more profitable for investors over the last year : 31.89 vs. RGAHX (3.25). BPTIX return over 5 years is better than : 169.65 vs. RGAHX (44.87).
BPTIXRGAHXBPTIX / RGAHX
Total Expense Ratio1.990.44452%
Annual Report Gross Expense Ratio1.990.44452%
Fund Existence16 years9 years-
Gain YTD-12.106-2.478489%
Front LoadN/AN/A-
Min. Initial Investment1000000250400,000%
Min. Initial Investment IRAN/AN/A-
Net Assets6.66B285B2%
Annual Yield % from dividends0.000.54-
Returns for 1 year31.893.25980%
Returns for 3 years32.4433.4097%
Returns for 5 years169.6544.87378%
Returns for 10 years397.09N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ARKO4.770.32
+7.19%
ARKO Corp
LYRA0.10N/A
+4.03%
Lyra Therapeutics
JJSF116.230.49
+0.42%
J & J Snack Foods Corp
CRL138.79-2.57
-1.82%
Charles River Laboratories International
FDMT3.08-0.16
-4.94%
4D Molecular Therapeutics